NB-UVB and PUVA Vitiligo Study

Henry Ford Health

Status and phase: Completed; Phase 4

Conditions: Vitiligo

Treatments: Other: Phototherapy; Other: Phototherapy and Photochemotherapy

Study type: Interventional

Funder types: Other

Identifiers

NCT01732965

HFHS Vitiligo Phototherapy

Details and patient eligibility

About

To evaluate if the combination of psoralen plus ultraviolet A and narrowband ultraviolet B is more effective than narrowband ultraviolet B alone in the treatment of vitiligo.

Enrollment: 10 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Vitiligo affecting more than 15% body surface area.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

10 participants in 2 patient groups, including a placebo group

NB-UVB phototherapy

Placebo Comparator group

Description:

NB-UVB alone

Treatment:

Other: Phototherapy

phototherapy and photochemotherapy

Experimental group

Description:

NB-UVB and PUVA

Treatment:

Other: Phototherapy and Photochemotherapy